Cthrc1 Is a Novel Inhibitor of Transforming Growth Factor-² Signaling and Neointimal Lesion Formation: Correction
Cthrc1 Is a Novel Inhibitor of Transforming Growth Factor-β Signaling and Neointimal Lesion Formation: Correction
In the article that appears on page 826 of the March 30, 2007 issue, the following sentence should have been included in the Sources of Funding section:
Additional support was provided by the Maine Medical Center Research Institute Histopathology Core Facility as supported by NIH P20RR18789 (DM Wojchowski, PI).
The authors apologize for this error, and the error has been noted and corrected in the online version of the article, which is available at http://circres.ahajournals.org/content/100/6/826.full.
- © 2012 American Heart Association, Inc.